BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Rhabdomyosarcoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
302 results:

  • 1. FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.
    de Traux De Wardin H; Cyrta J; Dermawan JK; Guillemot D; Orbach D; Aerts I; Pierron G; Antonescu CR
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23232. PubMed ID: 38607246
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    de Traux de Wardin H; Dermawan JK; Vanoli F; Jiang SC; Singer S; Chi P; Tap W; Wexler LH; Antonescu CR
    JCO Precis Oncol; 2024 Apr; 8():e2300597. PubMed ID: 38603649
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline Genetic Testing and Survival Outcomes Among Children With rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
    JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
    Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
    Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.
    Searcy MB; Larsen RK; Stevens BT; Zhang Y; Jin H; Drummond CJ; Langdon CG; Gadek KE; Vuong K; Reed KB; Garcia MR; Xu B; Kimbrough DW; Adkins GE; Djekidel N; Porter SN; Schreiner PA; Pruett-Miller SM; Abraham BJ; Rehg JE; Hatley ME
    Nat Commun; 2023 Nov; 14(1):7291. PubMed ID: 37968277
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
    Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
    Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Histopathologic "Evolution" in Pediatric Primary Intracranial High-Grade Sarcoma - a Key that Unlocked the Correct Diagnosis.
    Naik U; Shah M; Sandberg DI; Samant R; Roy A; Bhattacharjee MB
    Ann Clin Lab Sci; 2023 Jul; 53(4):661-666. PubMed ID: 37625831
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Complete loss of
    Beird HC; Wu CC; Nakazawa M; Ingram D; Daniele JR; Lazcano R; Little L; Davies C; Daw NC; Wani K; Wang WL; Song X; Gumbs C; Zhang J; Rubin B; Conley A; Flanagan AM; Lazar AJ; Futreal PA
    HGG Adv; 2023 Oct; 4(4):100224. PubMed ID: 37593416
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Establishment of a novel experimental system using single cell-derived pleomorphic rhabdomyosarcoma cell lines expressing K-RasG12V and deficient in p53.
    Saito H; Suzuki N
    Exp Anim; 2023 Nov; 72(4):446-453. PubMed ID: 37081671
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
    Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
    Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Cytotoxic Effect of Curcumin in rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling.
    Salucci S; Bavelloni A; Stella AB; Fabbri F; Vannini I; Piazzi M; Volkava K; Scotlandi K; Martinelli G; Faenza I; Blalock W
    Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771452
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Replication collisions induced by de-repressed S-phase transcription are connected with malignant transformation of adult stem cells.
    Zhang T; Künne C; Ding D; Günther S; Guo X; Zhou Y; Yuan X; Braun T
    Nat Commun; 2022 Nov; 13(1):6907. PubMed ID: 36376321
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Predicting Molecular Subtype and Survival of rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group.
    Milewski D; Jung H; Brown GT; Liu Y; Somerville B; Lisle C; Ladanyi M; Rudzinski ER; Choo-Wosoba H; Barkauskas DA; Lo T; Hall D; Linardic CM; Wei JS; Chou HC; Skapek SX; Venkatramani R; Bode PK; Steinberg SM; Zaki G; Kuznetsov IB; Hawkins DS; Shern JF; Collins J; Khan J
    Clin Cancer Res; 2023 Jan; 29(2):364-378. PubMed ID: 36346688
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cervical Pleuropulmonary Blastoma-like Tumor Associated With DICER1 and tp53 Mutations.
    Stolnicu S; Bartalis RJ; Mihut E; Szabo B; Da Cruz Paula A; Ye Q; Parkash V; Weigelt B; Soslow RA
    Int J Gynecol Pathol; 2023 Jul; 42(4):347-352. PubMed ID: 36302256
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function.
    Macha SJ; Koneru B; Burrow TA; Zhu C; Savitski D; Rahman RL; Ronaghan CA; Nance J; McCoy K; Eslinger C; Reynolds CP
    Cancer Res; 2022 Sep; 82(18):3345-3358. PubMed ID: 35947641
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes.
    Meister MT; Groot Koerkamp MJA; de Souza T; Breunis WB; Frazer-Mendelewska E; Brok M; DeMartino J; Manders F; Calandrini C; Kerstens HHD; Janse A; Dolman MEM; Eising S; Langenberg KPS; van Tuil M; Knops RRG; van Scheltinga ST; Hiemcke-Jiwa LS; Flucke U; Merks JHM; van Noesel MM; Tops BBJ; Hehir-Kwa JY; Kemmeren P; Molenaar JJ; van de Wetering M; van Boxtel R; Drost J; Holstege FCP
    EMBO Mol Med; 2022 Oct; 14(10):e16001. PubMed ID: 35916583
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epithelioid rhabdomyosarcoma at the High Parietal Area of the Head: A Case Report.
    Jung S; Bohner L; Schulte M; Kleinheinz J
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888670
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular and expressional characterization of tumor heterogeneity in pulmonary carcinosarcoma.
    Ohtaki Y; Kawabata-Iwakawa R; Nobusawa S; Goto Y; Shimizu K; Yajima T; Nakazawa S; Kawatani N; Yoshida Y; Sano T; Shirabe K
    Mol Carcinog; 2022 Oct; 61(10):924-932. PubMed ID: 35848137
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
    Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
    Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.